Θρόμβωση: Διαφορά μεταξύ των αναθεωρήσεων
Περιεχόμενο που διαγράφηκε Περιεχόμενο που προστέθηκε
μ Ρομπότ: Προσθήκη: ky:Тромбоз |
μ →Αναφορές: Διόρθωση λάθους CHECKWIKI #86 με τη χρήση AWB (8429) |
||
Γραμμή 83:
#labtestsonline > Hypercoagulable Disorders This article was last reviewed on May 23, 2007 and was last modified on March 6, 2010.
# Webster, GJ; Burroughs AK, Riordan SM (January 2005)."Review article: portal vein thrombosis -- new insights into aetiology and management". Alimentary Pharmacology & Therapeutics 21 (1): 1–9. [[doi:10.1111/j.1365-2036.2004.02301.x]].
#eMedicine Article on Internal Jugular Vein Thrombosis by Dr. Dale K. Mueller|
#Canhão, P; Ferro JM, Lindgren AG et al. (August 2005)."Causes and predictors of death in cerebral venous thrombosis". Stroke 36 (8): 1720–1725. [[doi:10.1161/01.STR.0000173152.84438.1c]].
#Hatzinikolaou-Kotsakou E, Kartasis Z, Tziakas D, et al. (March 2005)."Clotting state after cardioversion of atrial fibrillation: a haemostasis index could detect the relationship with the arrhythmia duration". Thromb J 3 (1): 2. [[doi:10.1186/1477-9560-3-2. PMC 555849]].
Γραμμή 91:
#a b Hunt BJ (March 2008)."Awareness and politics of venous thromboembolism in the United kingdom". Arterioscler. Thromb. Vasc. Biol. 28 (3): 398–9. [[doi:10.1161/ATVBAHA.108.162586]].
#National Institute for Health and Clinical Excellence. Clinical guideline 46: Venous thromboembolism (surgical). London, April 2007.
#Geerts WH, Pineo GF, Heit JA, et al. (September 2004)."Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy". Chest 126 (3 Suppl): 338S–400S. [[doi:10.1378/chest.126.
#Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA (February 2007)."Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients". Ann. Intern. Med. 146 (4): 278–88.
[[Κατηγορία:Αίμα]]
| |||